{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:47:14Z","timestamp":1790286434971,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009983","name":"Center for Molecular Medicine Cologne, University of Cologne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ajpath.2019.05.008","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T02:42:12Z","timestamp":1560307332000},"page":"1831-1845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Neutral Sphingomyelinase 2 (SMPD3) Deficiency in Mice Causes Chondrodysplasia with Unimpaired Skeletal Mineralization"],"prefix":"10.1016","volume":"189","author":[{"given":"Wilhelm","family":"Stoffel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Hammels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Jenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Schmidt-Soltau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Niehoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2019.05.008_bib1","doi-asserted-by":"crossref","first-page":"25847","DOI":"10.1074\/jbc.R200008200","article-title":"The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind","volume":"277","author":"Hannun","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2019.05.008_bib2","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1073\/pnas.95.7.3638","article-title":"Cloned\u00a0mammalian neutral sphingomyelinase: functions in sphingolipid signaling?","volume":"95","author":"Tomiuk","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2019.05.008_bib3","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1073\/pnas.97.11.5895","article-title":"Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase","volume":"97","author":"Hofmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2019.05.008_bib4","doi-asserted-by":"crossref","first-page":"17993","DOI":"10.1074\/jbc.M110.102988","article-title":"Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5","volume":"285","author":"Wu","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2019.05.008_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0968-0004(99)01410-3","article-title":"Reply to kolesnick and hannun, and perry and hannun","volume":"24","author":"Hofmann","year":"1999","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ajpath.2019.05.008_bib6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0092-8674(05)80010-8","article-title":"Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease)","volume":"81","author":"Otterbach","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2019.05.008_bib7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ng0795-288","article-title":"Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease","volume":"10","author":"Horinouchi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2019.05.008_bib8","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1128\/MCB.22.11.3633-3638.2002","article-title":"Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease","volume":"22","author":"Zumbansen","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2019.05.008_bib9","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1073\/pnas.0406380102","article-title":"Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development","volume":"102","author":"Stoffel","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2019.05.008_bib10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0968-0004(98)01289-4","article-title":"Ceramide in apoptosis--does it really matter?","volume":"23","author":"Hofmann","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ajpath.2019.05.008_bib11","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1074\/jbc.275.8.5710","article-title":"Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase","volume":"275","author":"Tomiuk","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2019.05.008_bib12","doi-asserted-by":"crossref","first-page":"10904","DOI":"10.1074\/jbc.272.16.10904","article-title":"Tumor necrosis factor alpha activates NF-kappaB in acid sphingomyelinase-deficient mouse embryonic fibroblasts","volume":"272","author":"Zumbansen","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2019.05.008_bib13","doi-asserted-by":"crossref","first-page":"e2488","DOI":"10.1038\/cddis.2016.385","article-title":"Neutral sphingomyelinase (SMPD3) deficiency disrupts the Golgi secretory pathway and causes growth inhibition","volume":"7","author":"Stoffel","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2019.05.008_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/oxfordjournals.jhered.a109554","article-title":"Fragilitas ossium: a new autosomal recessive mutation in the mouse","volume":"72","author":"Guenet","year":"1981","journal-title":"J Hered"},{"key":"10.1016\/j.ajpath.2019.05.008_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ng1603","article-title":"A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse","volume":"37","author":"Aubin","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2019.05.008_bib16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00335-012-9419-x","article-title":"Neutral sphingomyelinase 2 deficiency is associated with lung anomalies similar to emphysema","volume":"23","author":"Poirier","year":"2012","journal-title":"Mamm Genome"},{"key":"10.1016\/j.ajpath.2019.05.008_bib17","series-title":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council: Guide for the Care and Use of Laboratory Animals: Eighth Edition","year":"2011"},{"key":"10.1016\/j.ajpath.2019.05.008_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"2","author":"Kilkenny","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.ajpath.2019.05.008_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-1-59745-104-8_19","article-title":"Micro-computed tomography: a method for the non-destructive evaluation of the three-dimensional structure of biological specimens","volume":"455","author":"Stauber","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ajpath.2019.05.008_bib20","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1210\/endo.142.5.8148","article-title":"Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology","volume":"142","author":"Butler","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2019.05.008_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/edrv-10-1-68","article-title":"Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations","volume":"10","author":"Daughaday","year":"1989","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajpath.2019.05.008_bib22","first-page":"955","article-title":"Genetics of mouse growth","volume":"42","author":"Efstratiadis","year":"1998","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.ajpath.2019.05.008_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1043-2760(00)00349-0","article-title":"What is the role of circulating IGF-I?","volume":"12","author":"Le Roith","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2019.05.008_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/dbio.2000.9975","article-title":"Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth","volume":"229","author":"Lupu","year":"2001","journal-title":"Dev Biol"},{"key":"10.1016\/j.ajpath.2019.05.008_bib25","first-page":"59","article-title":"Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)","volume":"75","author":"Liu","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2019.05.008_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1432-0436.1985.tb00316.x","article-title":"A dual effector theory of growth-hormone action","volume":"29","author":"Green","year":"1985","journal-title":"Differentiation"},{"key":"10.1016\/j.ajpath.2019.05.008_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40510-018-0216-2","article-title":"Role of osteopontin in bone remodeling and orthodontic tooth movement: a review","volume":"19","author":"Singh","year":"2018","journal-title":"Prog Orthod"},{"key":"10.1016\/j.ajpath.2019.05.008_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00774-015-0734-7","article-title":"An overview of osteocalcin progress","volume":"34","author":"Li","year":"2016","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ajpath.2019.05.008_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1083\/jcb.201102051","article-title":"A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization","volume":"194","author":"Khavandgar","year":"2011","journal-title":"J Cell Biol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944018309611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944018309611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:34:15Z","timestamp":1757694855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944018309611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0002944018309611"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2019.05.008","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutral Sphingomyelinase 2 (SMPD3) Deficiency in Mice Causes Chondrodysplasia with Unimpaired Skeletal Mineralization","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2019.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}